Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sulforaphane in a New Jersey (NJ) Population of Individuals With Autism
Sponsor: Rutgers, The State University of New Jersey
Summary
This study is a double blind treatment trial that will test if sulforaphane improves core symptoms in autism. The investigators expect to see clinical improvement in some of these areas. Sulforaphanes come from eating certain vegetables such as broccoli. The investigators will be using a preparation that gives specific and reproducible amounts. The investigators will also test specific chemicals and genes needed for sulforaphane usage to try to understand differences in response.
Official title: Sulforaphane in Autism: A Treatment Trial to Confirm Phenotypic Improvement With Sulforaphane Treatment in a New Jersey (NJ) Population of Individuals With Autism
Key Details
Gender
MALE
Age Range
13 Years - 30 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2016-02
Completion Date
2026-03
Last Updated
2025-10-29
Healthy Volunteers
No
Interventions
Sulforaphane
Sulforaphane (1-isothiocyanato-4R- (methylsulfinyl)butane) is an isothiocyanate derived from the action of the plant enzyme myrosinase on glucosinolates including glucoraphanin and comes from consumption of many cruciferous vegetables.
Placebo
Locations (1)
Rutgers University - Staged Research Building
Piscataway, New Jersey, United States